Rett's syndrome

• X-linked dominant (XD)

• Mutation in MECP-2 gene (Methyl-CpG-binding protein 2)

• Common in girls (female)

• Severe mental retardation 

• Microcephaly after birth (Acquired microcephaly)

• Seizures in 75% cases

• Normal developmental upto 5 months to 1 year and loss of milestones after that.

 

Treatment: Symptomatic 

• Anticonvulsants - for Seizure

• Behaviour therapy - for Self injury

• Physiotherapy - for Muscle deformity

 

NOTE: Trofinetide (FDA approved March 2023)

Trofinetide- 

It’s a simple tripeptide with the sequence Gly-Pro-Glu (Glycine-Proline-Glutamate; GPE). 

 

This tripeptide (GPE) is derived from the enzymatic cleavage of Insulin-like Growth Factor-1 (IGF-1)in the brain.

 

Treatment of Rett syndrome in people two years of age and older.

 

It is believed to:

• Reduce neuroinflammation

• Improve neuronal and synaptic function

• Enhance brain-derived neurotrophic factor (BDNF) pathways

• Improve microglial function

View in web app Open in TCML App